We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHC
501
DELISTED
Leo Holdings Corp. II
LHC
| $18.1M | 0.04% |
1,813,861
| – | – |
|
|
NSTD
502
DELISTED
Northern Star Investment Corp. IV
NSTD
| $18M | 0.04% |
1,834,634
+155,536
| +9% | +$1.53M |
|
|
503
CALL
UnitedHealth
UNH
$382B
| $18M | 0.04% |
+35,600
| New | +$18.7M |
|
|
TETC
504
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $18M | 0.04% |
1,820,517
| – | – |
|
505
Amgen
AMGN
$203B
| $17.9M | 0.04% |
79,564
-178,664
| -69% | -$43.3M |
|
506
Ameriprise Financial
AMP
$46.8B
| $17.9M | 0.04% |
70,894
-94,075
| -57% | -$24.8M |
|
507
Aptiv
APTV
$12B
| $17.8M | 0.04% |
228,044
-396,537
| -63% | -$38M |
|
|
SPLK
508
DELISTED
Splunk Inc
SPLK
| $17.8M | 0.04% |
237,072
-203,039
| -46% | -$19.9M |
|
|
EMBJ
509
Embraer S.A. ADS
EMBJ
$11.6B
| $17.8M | 0.04% |
2,071,964
-1,504,961
| -42% | -$14.9M |
|
510
ICL Group
ICL
$6.81B
| $17.8M | 0.04% |
2,178,378
+29,396
| +1% | +$275K |
|
511
Bloom Energy
BE
$52.6B
| $17.8M | 0.04% |
890,737
-143,490
| -14% | -$3.23M |
|
|
ARCH
512
DELISTED
Arch Resources, Inc.
ARCH
| $17.7M | 0.04% |
149,232
-13,241
| -8% | -$1.83M |
|
513
Sibanye-Stillwater
SBSW
$5.92B
| $17.7M | 0.04% |
1,894,121
+1,049,646
| +124% | +$9.97M |
|
|
BLU
514
DELISTED
BELLUS Health Inc.
BLU
| $17.5M | 0.04% |
1,658,982
+896,878
| +118% | +$9.53M |
|
|
PCPC
515
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $17.5M | 0.04% |
706,390
| – | – |
|
516
CALL
Visa
V
$677B
| $17.4M | 0.04% |
98,200
-283,600
| -74% | -$57.7M |
|
517
Royalty Pharma
RPRX
$26.1B
| $17.4M | 0.04% |
+432,250
| New | +$18.5M |
|
518
HEICO Corp
HEI
$48.9B
| $17.4M | 0.04% |
120,581
-65,648
| -35% | -$9.84M |
|
|
JOYY
519
JOYY Inc
JOYY
$3.73B
| $17.3M | 0.04% |
664,850
+387,706
| +140% | +$10.6M |
|
|
WPCB
520
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $17.2M | 0.04% |
1,732,872
+23,904
| +1% | +$236K |
|
521
Wheaton Precious Metals
WPM
$50.6B
| $17.1M | 0.04% |
528,221
-241,936
| -31% | -$7.95M |
|
|
SPGS
522
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $17.1M | 0.04% |
1,734,448
| – | – |
|
523
Vail Resorts
MTN
$5.19B
| $17.1M | 0.04% |
79,227
-62,847
| -44% | -$14.3M |
|
524
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $17M | 0.04% |
576,900
-227,500
| -28% | -$7.06M |
|
525
GoodRx Holdings
GDRX
$1B
| $16.9M | 0.04% |
3,622,709
+55,218
| +2% | +$348K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.